Product Information
BAQSIMI 3 MG SPRAY ONE PACK is a brand product labeled by Amphastar Pharmaceuticals, Inc., priced at $292.9801 per EA under NDC 00548835101. Its NADAC has been published 131 times since Apr 3, 2024.
FDA first approved this application on Jul 24, 2019.
Strength
3 mg/1
Manufacturer
Amphastar Pharmaceuticals, Inc.NDC
00548835101
Classification
Brand
Dosage Form
POWDER
Route
NASAL
Effective Date
9/23/2026
Active Ingredients
GLUCAGONApproval Type
New Drug (NDA)
FDA Application
NDA210134FDA Approved
7/24/2019
On Market Since
7/24/2019
Pharmacological Classes
Price Statistics
The NADAC for BAQSIMI 3 MG SPRAY ONE PACK has been published 131 times since Apr 3, 2024, and over the history we have for it it has risen 8.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $292.9801 per EA |
|---|---|
| All-time high | $293.3876 (Sep 16, 2026) |
| All-time low | $269.0743 (Apr 3, 2024) |
| 52-week high | $293.3876 |
| 52-week low | $284.8254 |
| Median price | $284.8336 |
| Average price | $283.4767 |
| Largest weekly change | +3.0% (Jan 1, 2025) |
| Weeks tracked | 131 |
| Tracking since | Apr 3, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amphastar Pharmaceuticals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
glucagon market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antihypoglycemic Agent class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BAQSIMI 3 MG SPRAY ONE PACK?
The current National Average Drug Acquisition Cost (NADAC) for BAQSIMI 3 MG SPRAY ONE PACK, manufactured by Amphastar Pharmaceuticals, Inc., is $292.9801 per EA (NDC 00548835101), effective Sep 30, 2026.
How has the price of BAQSIMI 3 MG SPRAY ONE PACK changed over time?
Over the history we have for it, the NADAC for BAQSIMI 3 MG SPRAY ONE PACK has risen 8.9%. It has been tracked across 131 weekly CMS publications since Apr 3, 2024.
What are the highest and lowest recorded NADAC prices for BAQSIMI 3 MG SPRAY ONE PACK?
Since Apr 3, 2024, the NADAC for BAQSIMI 3 MG SPRAY ONE PACK has ranged from a low of $269.0743 (Apr 3, 2024) to a high of $293.3876 (Sep 16, 2026), with a median of $284.8336 per EA.
Are there cheaper alternatives to BAQSIMI 3 MG SPRAY ONE PACK?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as BAQSIMI 3 MG SPRAY ONE PACK in a comparable dosage form, but none are currently priced below it.
Who manufactures BAQSIMI 3 MG SPRAY ONE PACK?
BAQSIMI 3 MG SPRAY ONE PACK (NDC 00548835101) is labeled by Amphastar Pharmaceuticals, Inc., and CMS classifies it as a brand product.